Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Niranjan Patra"'
Publikováno v:
Beilstein Journal of Nanotechnology, Vol 8, Iss 1, Pp 2026-2031 (2017)
A polymer nanocomposite was produced by ultrasonic-assisted dispersion of multiwalled carbon nanotubes (MWCNTs) in a polycarbonate matrix using p-xylene and dichloromethane as the solvents. The filler loading was varied from 1 to 3 wt % in order to e
Externí odkaz:
https://doaj.org/article/8d64f648d4d14a76aa7771f733a52b98
Autor:
Deepak Kumar Sarangi, Chandra Sekhar Patro, Ch. Niranjan Patra, Nalini Kanta Sahoo, Nihar Ranjan Das, Komalpreet Kaur, Jahanvi Gupta
Publikováno v:
Results in Chemistry, Vol 9, Iss , Pp 101652- (2024)
The purpose of this study was to prepare and evaluate multiple unit mini tablets (MTs) of prolonged released (PR) bosentan (BSN) and fast release (FR) sildenafil citrate (SDC) on the basis of encapsulation method for the effective management of pulmo
Externí odkaz:
https://doaj.org/article/42365d7901a94bcdbab73ca9850fdf5d
Publikováno v:
Journal of Bio-X Research, Vol 7 (2024)
Artificial intelligence (AI) and machine learning (ML) are revolutionizing the pharmaceutical industry, particularly in drug development and delivery. These technologies enable precision medicine by analyzing extensive datasets to optimize formulatio
Externí odkaz:
https://doaj.org/article/f42e92d37a664836892d2d6638b50c6b
Autor:
Jayanti Panda, Muddana Eswara Bhanoji Rao, Suryakanta Swain, Chinam Niranjan Patra, Bikash Ranjan Jena
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 11, Iss 1, Pp 1-15 (2022)
Abstract Background The current study expands on the use of design of experiment in developing cefuroxime axetil mucoadhesive minitablets for treating antibiotic-associated colitis. A comprehensive QbD-based product development strategy was implement
Externí odkaz:
https://doaj.org/article/42c08b420c2a46a29b0294d86f5583b3
Publikováno v:
Journal of Pharmacy and Bioallied Sciences, Vol 13, Iss 4, Pp 360-366 (2021)
Context: There is no straightforward method for estimating cinacalcet HCl in biological materials such as serum exists. As a result, the goal of this research is to develop a simple quality by design (QbD) enabled reverse phase-Ultra-Fast Liquid Chro
Externí odkaz:
https://doaj.org/article/6e789fb2fc414f08a17476910e848cf7
Publikováno v:
Current Materials Science. 16:30-42
Background: Active pharmaceutical ingredient to be administered in a suitable dosage form is usually incorporated with an inert substance (excipient) to achieve a necessary therapeutic effect. Pharmaceutical excipient plays a prominent role in the dr
Publikováno v:
Research Journal of Pharmacy and Technology. :955-961
The utility of lipid-based oral formulations has been familiar for many years. There are an enormous variety of polymeric materials used to modify the delivery platform along with enhancement of therapeutic efficacy. Gelucires are a family of lipid-b
Autor:
Deepak Sarangi, Chandra Sekhar Patro, Ch. Niranjan Patra, Gurudutta Pattnaik, Jnyanranjan Panda
Publikováno v:
International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN). 16:6325-6336
As a new approach to solid dosage forms, mini-tablets (MTs) are designed to subjugate some kind of therapeutic disincentives, like poor swallowing properties and polypharmacy therapy, as well as to provide therapeutic advantages like dose flexibility
Autor:
Suryakanta Swain, Debashish Ghose, Chinam Niranjan Patra, Bikash Ranjan Jena, Muddana Eswara Bhanoji Rao
Publikováno v:
Current Pharmaceutical Biotechnology. 24:213-237
Abstract: Platelet-inspired nanoparticles have ignited the possibility of new opportunities for producing similar biological particulates, such as structural cellular and vesicular components, as well as various viral forms, to improve biocompatible
Autor:
A. Eswar Kumar, Ch. Niranjan Patra
Publikováno v:
Research Journal of Pharmacy and Technology. :5565-5570
The present investigation deals with the development of duloxetine ethosome then loading into transdermal patch to impart lower drug side effect, enhanced bioavailability, avoid first pass metabolismt.32 factorial design was applied to optimize the f